REGENXBIO Inc. - 8-K Filing
REGENXBIO held its 2026 Annual Meeting on May 29 with approximately 83% of shares voting; directors Jean Bennett, Jerry Karabelas, and Daniel Tassé were elected. Shareholders approved a stock option exchange program for non-executive employees starting June 3, which allows exchanging certain options for new ones at fair market value. (Items: 5.07 Submission of Matters to a Vote of Security Holders, 8.01 Other Events)
Tickers: $RGNX